This inventor holds 3 USPTO granted patents. Top assignees: Cytran, Inc., Cytran Incorporation. Active years: 2000-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2002
Title: The Innovative Contributions of Boris V Vaskovsky
Introduction: Boris V Vaskovsky, an accomplished inventor based in Moscow, RU, is known for his significant contributions to the field of immunology. With three patents to his name, Vaskovsky has focused on developing pharmaceutical compositions that address various immune-related conditions.
Latest Patents: Vaskovsky's latest patents include groundbreaking inventions such as pharmaceutical lysine-containing polypeptide compositions and methods of use, which aim to provide therapy for immunodeficient or immunodepressed individuals. These compositions contain peptides formulated as R'-L-Glx-L-Glx-L-Lys-R' and are designed to treat opportunistic infections. Additionally, he has developed immunomodulating peptides, specifically those structured as R'-Glx-Glx-Lys-R', including peptides like Thr-Ala-Glu-Glu-Lys and Thr-Pro-Glu-Glu-Lys, which are included in pharmaceutical compositions aimed at immunomodulation.
Career Highlights: Boris V Vaskovsky has had a fruitful career, working at notable companies including Cytran, Inc. and Cytran Incorporation. His experience in these organizations has allowed him to refine his expertise in developing therapies that address pressing health challenges.
Collaborations: Throughout his career, Vaskovsky has collaborated with prominent professionals in his field, including Lawrence R Green and Vadim T Ivanov. These partnerships have contributed to his innovative research and the successful development of his patents.
Conclusion: Boris V Vaskovsky stands out as a notable inventor in the realm of immunology, with a specialization in the creation of pharmaceutical compositions that can potentially transform treatment approaches for immune disorders. His ongoing contributions to science showcase the impact of innovation in improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile